You are here:

Home
NICE Guidance
Conditions and diseases
Infections
COVID-19

RespiraSense for continuously monitoring respiratory rate

Medtech innovation briefing
Reference number: MIB299
Published: 05 July 2022

Download (PDF)

Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing

Regulatory information

RespiraSense is a CE marked IIb medical device.

Next page Equality considerations Previous page The technology